Author:
Pinheiro Simone P.,Rivera Donna R.,Graham David J.,Freedman Andrew N.,Major Jacqueline M.,Penberthy Lynne,Levenson Mark,Bradley Marie C.,Wong Hui-Lee,Ouellet-Hellstrom Rita
Reference24 articles.
1. US Food and Drug Administration. Methodological considerations in evaluation of cancer as an adverse outcome associated with use of non-biological drugs and biological products in the post-approval setting; public meeting. Presentations, transcripts, agenda background Mater available. Available at: http://www.fda.gov/Drugs/NewsEvents/ucm401452.htm. [accessed 20.12.2014].
2. Hallmarks of cancer: the next generation;Hanahan;Cell,2011
3. Colorectal cancer: molecules and populations;Potter;J Natl Cancer Inst,1999
4. Journeys into the genome of cancer cells;Stratton;EMBO Mol Med,2013
5. Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms;Chia;Nat Rev Clin Oncol,2012
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献